Hiroyuki Hao

Prof. Hiroyuki Hao

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2019 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
OGon behalf of the Japan TGCV study group
on behalf of the Japan TGCV study group
MLMing Li
Ming Li
KHKen-Ichi Hirano
Ken-Ichi Hirano
YIYoshihiko Ikeda
Yoshihiko Ikeda
MHMasahiro Higashi
Masahiro Higashi
KKKunihisa Kobayashi
Kunihisa Kobayashi
Triglyceride deposit cardiomyovasculopathy (TGCV) is a phenotype primarily reported in patients carrying genetic mutations in PNPLA2 encoding adipose triglyceride lipase (ATGL) which releases long chain fatty acid (LCFA) as a major energy source by the intracellular TG hydrolysis. These patients suffered from intractable heart failure requiring cardiac transplantation. Moreover, we identified TGCV patients without PNPLA2 mutations based on pathological and clinical studies. We provided the diagnostic criteria, in which TGCV with and without PNPLA2 mutations were designated as primary TGCV (P-TGCV) and idiopathic TGCV (I-TGCV), respectively. We hereby report clinical profiles of TGCV patients. Between 2014 and 2018, 7 P-TGCV and 18 I-TGCV Japanese patients have been registered in the International Registry. Patients with I-TGCV, of which etiologies and causes are not known yet, suffered from adult-onset severe heart disease, including heart failure and coronary artery disease, associated with a marked reduction in ATGL activity and myocardial washout rate of LCFA tracer, as similar to those with P-TGCV. The present first registry-based study showed that TGCV is an intractable, at least at the moment, and heterogeneous cardiovascular disorder.

18 February 2021 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
NONaoto Otsuka
Naoto Otsuka
YOYasuo Okumura
Yasuo Okumura
MAMasaru Arai
Masaru Arai
SKSayaka Kurokawa
Sayaka Kurokawa
KNKoichi Nagashima
Koichi Nagashima
YLYxin Li
Yxin Li

19 July 2022 in Placenta
Verified
Journal Article
Closed access
KTKazuhide Takada
Kazuhide Takada
SSSayaka Shimodai-Yamada
Sayaka Shimodai-Yamada
MSMayumi Suzuki
Mayumi Suzuki
QTQuang Duy Trinh
Quang Duy Trinh
CTChika Takano
Chika Takano
SKShihoko Komine-Aizawa
Shihoko Komine-Aizawa

28 October 2021 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
NONaoto Otsuka
Naoto Otsuka
YOYasuo Okumura
Yasuo Okumura
SKSayaka Kuorkawa
Sayaka Kuorkawa
KNKoichi Nagashima
Koichi Nagashima
YWYuji Wakamatsu
Yuji Wakamatsu
YTYoshiki Taniguchi
Yoshiki Taniguchi

1 June 2013 in EuroIntervention
Verified
Journal Article
Closed access
KMKoshi Matsuo
Koshi Matsuo
YUYasunori Ueda
Yasunori Ueda
MTMasahiko Tsujimoto
Masahiko Tsujimoto
HHHiroyuki Hao
Hiroyuki Hao
MNMayu Nishio
Mayu Nishio
KKKazuhisa Kodama
Kazuhisa Kodama
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

1 January 2014 in Circulation Journal
Verified
Journal Article
Open access
PDF file
MNMayu Nishio
Mayu Nishio
YUYasunori Ueda
Yasunori Ueda
KMKoshi Matsuo
Koshi Matsuo
MTMasahiko Tsujimoto
Masahiko Tsujimoto
HHHiroyuki Hao
Hiroyuki Hao
KKKazuhisa Kodama
Kazuhisa Kodama
Background:The slow-flow or no re-flow phenomenon has been associated with distal embolization, especially of plaque debris, and with unfavorable clinical outcomes. Therefore, we examined the association between the coronary computed tomography angiography (CCTA) findings of the target lesion and distal embolization during percutaneous coronary intervention (PCI).Methods and Results:Consecutive patients (n=55: 18 unstable angina, 19 stable effort angina, 18 silent ischemia) who underwent PCI with a filter-type distal protection device after evaluation of the target lesion by CCTA were analyzed. CCTA examined low-attenuation plaque (LAP), positive remodeling (PR), and ring-like enhancement of the target lesion. Distal embolization of thrombus and plaque debris was evaluated by pathological examination of material collected in the filter. Any distal embolization and distal embolization of plaque debris were respectively detected in 75% and 0% of patients with LAP or PR alone, in 95% and 17% of patients with both LAP and PR, and in 100% and 27% of patients with all of LAP, PR and ring-like enhancement. The sensitivity and specificity to predict plaque debris embolization by having both findings of LAP and PR was 100% and 46%, respectively.Conclusions:The CCTA findings of the target lesion were associated with distal embolization and were very sensitive for predicting plaque debris embolization. (Circ J2014;78:2203–2208)